Point-of-care lateral flow diagnostic under development with BARDA funding for rapid detection of Burkholderia pseudomallei. Designed to enable detection of melioidosis in field and clinical settings.
Manufactured by
InBios International, Inc.
United States
Since 1996, InBios has been a leader in the development of diagnostic tests for emerging infectious diseases and biothreats. Products are designed for superior performance, efficiency and value. These include many FDA market authorized and CE marked assays for arboviruses, parasitic infections, biothreats, and more. InBios continues to anticipate and serve the growing global public health demand. Products in the pipeline include next generation platforms for tick-borne and respiratory diseases.
© 2026 Suplivia · Home · Browse Products